<DOC>
	<DOCNO>NCT00764049</DOCNO>
	<brief_summary>The aim study determine whether simplified device albumin dialysis also beneficial effect .</brief_summary>
	<brief_title>Single Pass Albumin Dialysis Patients With Cirrhosis</brief_title>
	<detailed_description>Albumin dialysis beneficial effect patient acute chronic liver failure . However , current device complex costly . The aim study determine whether simplified device albumin dialysis also beneficial effect .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>End Stage Liver Disease</mesh_term>
	<mesh_term>Acute-On-Chronic Liver Failure</mesh_term>
	<mesh_term>Hepatorenal Syndrome</mesh_term>
	<mesh_term>Liver Failure , Acute</mesh_term>
	<criteria>Minimum age 18 year Written consent information patient , case inability , parent close present . Patient cirrhosis research previous exam ( liver biopsy ) , absence previous diagnosis , diagnose view result clinical , biological morphological data , whatever origin cirrhosis ( virus hepatitis B , virus hepatitis C , extreme consumption alcohol reason ) Participation study 4 week Active digestive bleeding , unchecked pharmacological treatment endoscopic technique .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Albumin dialysis</keyword>
	<keyword>Artificial liver support</keyword>
	<keyword>Acute chronic liver failure</keyword>
</DOC>